You are here

Faculty - Virginia (Ginny) Conley

Virginia (Ginny) Conley
PhD, ARNP, FNP-BC, PMHNP-BC, FAANP
Professor (Clinical)
476 CNB
319-335-7017
Education: 

PhD, University of South Florida
Post Graduate PMHNP Certificate, University of Wyoming
MSN, University of Wyoming
BSN, Excelsior College
RN, Deaconess Hospital School of Nursing

Research Focus/Clinical Interests: 
  • Pharmacogenomics
  • Schizophrenia
  • Integrated mental and primary health care
  • Rural health care
  • Nursing education

Virginia (Ginny) Conley is a dually certified nurse practitioner who has extensive experience teaching and coordinating PMHNP and FNP programs. She began her academic career at the University of Wyoming where she taught in and directed the FNP program. Since coming to the University of Iowa in 2010 she has taught in both FNP and PMHNP programs, and she served as the PMHNP program coordinator and as the Director of the DNP and MSN/CNL Programs. She co-authored the Screening, Brief Intervention and Referral to Treatment (SBIRT) training grant from the Substance Abuse and Mental Health services Administration (SAMHSA) that was implemented in primary care NP programs. She received the College of Nursing Collegiate Teaching Award in 2014.

Dr. Conley practices two days a week at a Program for Assertive Community Treatment (PACT) where she is a member of a team that provides comprehensive services for persons with severe mental illness. In that setting she implemented a quality improvement project that focused on the use of pharmacogenomics in the prescription decision making process.

Dr. Conley is a Fellow in the American Association of Nurse Practitioners (AANP), and the recipient of the 2008 AANP State Award for Excellence in Practice. She is currently a mentor in the FAANP Mentorship Program. She is also a member of the National Organization of Nurse Practitioner Faculty, the American Psychiatric Nurses Association, and the International Society of Nurses in Genetics. She has been an invited speaker on mental health issues and the implementation of pharmacogenomics into clinical practice state-wide and nationally.